Vaughan Nelson Investment Management L.P. Sells 715 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Vaughan Nelson Investment Management L.P. lessened its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 25.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,055 shares of the medical equipment provider’s stock after selling 715 shares during the quarter. Vaughan Nelson Investment Management L.P.’s holdings in Intuitive Surgical were worth $1,073,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently modified their holdings of the company. Stephens Inc. AR boosted its holdings in shares of Intuitive Surgical by 8.9% during the 4th quarter. Stephens Inc. AR now owns 8,943 shares of the medical equipment provider’s stock valued at $4,668,000 after acquiring an additional 732 shares during the last quarter. Howland Capital Management LLC boosted its holdings in Intuitive Surgical by 8.2% in the fourth quarter. Howland Capital Management LLC now owns 4,202 shares of the medical equipment provider’s stock worth $2,193,000 after purchasing an additional 320 shares during the last quarter. Quotient Wealth Partners LLC raised its stake in Intuitive Surgical by 6.4% during the 4th quarter. Quotient Wealth Partners LLC now owns 1,619 shares of the medical equipment provider’s stock valued at $845,000 after buying an additional 97 shares during the last quarter. Northeast Investment Management raised its stake in Intuitive Surgical by 3.1% during the 4th quarter. Northeast Investment Management now owns 89,170 shares of the medical equipment provider’s stock valued at $46,543,000 after buying an additional 2,685 shares during the last quarter. Finally, Empowered Funds LLC lifted its holdings in shares of Intuitive Surgical by 181.4% during the 4th quarter. Empowered Funds LLC now owns 23,006 shares of the medical equipment provider’s stock valued at $12,008,000 after buying an additional 14,829 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

ISRG opened at $582.98 on Monday. The stock has a market capitalization of $207.65 billion, a price-to-earnings ratio of 90.95, a PEG ratio of 5.67 and a beta of 1.39. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The company has a fifty day moving average of $554.85 and a 200 day moving average of $514.38.

Insider Activity

In related news, CFO Jamie Samath sold 108 shares of the firm’s stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total value of $58,542.48. Following the completion of the transaction, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at approximately $4,746,819.42. This trade represents a 1.22 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the sale, the director now directly owns 12,275 shares in the company, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 5,671 shares of company stock worth $3,188,254 over the last 90 days. Corporate insiders own 0.90% of the company’s stock.

Wall Street Analysts Forecast Growth

ISRG has been the subject of several research analyst reports. Jefferies Financial Group lifted their price objective on Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. UBS Group boosted their price target on Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research note on Monday, January 27th. Bernstein Bank raised their price objective on shares of Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a report on Monday, January 27th. BTIG Research upped their target price on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. Finally, Barclays increased their price target on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.